Business Wire India
Takeda Pharmaceutical Company Limited (TSE: 4502 / NYSE: TAK) (“Takeda”) will present on Monday, January 11, 2021 / 7:20 at JT’s 39th annual JP Morgan Healthcare Conference on Tuesday, January 12, 2021 at 6 am. Invited to listen to live webcast with investor and general public Christophe Weber, President and Chief Executive Officer here. The replay of the webcast will also be stored at the same location. The link to the webcast and the slide for download will also be available on Takeda’s website https://www.takeda.com/investors/ir-events/.
About TAKEDA Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited (TSE: 4502 / NYSE: TAK) Is a global, value-based, R&D-driven biopharmaceutical leader headquartered in Japan committed to discovering and delivering life-changing treatments guided by our commitment to patients, our people, and the planet. Takeda focuses its R&D efforts on four therapeutic areas: oncology, RERA genetic and hematology, neuroscience and gastroenterology (GI). We also make targeted R&D investments in plasma-derived therapies and vaccines. We are focused on developing highly innovative drugs that transform people’s lives by expanding the range of new treatment options and leveraging our augmented collaborative R&D engine and creating a robust, modern-diversified pipeline. Contribute. Our staff is committed to improving the quality of life for patients and working with our partners in healthcare in nearly 80 countries. For more information, visit https://www.takeda.com.
The content is by Business Wire India. Tech Media is not responsible for the content provided or any link related to this content. Tech Media is not responsible for the accuracy, timeliness or quality of content.